Ticker
SPRBCompany Name
SPRUCE BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 21.82M | $ 16.39M | 75.1% |
3/31/2025 | $ 31.65M | $ 25.61M | 80.93% |
12/31/2024 | $ 45.21M | $ 38.75M | 85.72% |
9/30/2024 | $ 65.1M | $ 60.05M | 92.25% |
6/30/2024 | $ 75.52M | $ 69.68M | 92.27% |
3/31/2024 | $ 87.54M | $ 81.15M | 92.71% |
12/31/2023 | $ 103.95M | $ 96.34M | 92.68% |
9/30/2023 | $ 112.98M | $ 98.8M | 87.45% |
6/30/2023 | $ 125.96M | $ 97.48M | 77.39% |
3/31/2023 | $ 139.11M | $ 73.93M | 53.14% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for SPRUCE BIOSCIENCES INC is calculated as follows: CashnEq [ $ 72.37M ] / Assets [ $ 78.48M ]
(=) Cash to Assets [ 92.21% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |